180 related articles for article (PubMed ID: 16600502)
1. Autoantibodies that recognize functional domains of hnRNPA1 implicate molecular mimicry in the pathogenesis of neurological disease.
Lee SM; Dunnavant FD; Jang H; Zunt J; Levin MC
Neurosci Lett; 2006 Jun; 401(1-2):188-93. PubMed ID: 16600502
[TBL] [Abstract][Full Text] [Related]
2. Molecular mimicry: cross-reactive antibodies from patients with immune-mediated neurologic disease inhibit neuronal firing.
Kalume F; Lee SM; Morcos Y; Callaway JC; Levin MC
J Neurosci Res; 2004 Jul; 77(1):82-9. PubMed ID: 15197740
[TBL] [Abstract][Full Text] [Related]
3. HTLV-1 induced molecular mimicry in neurological disease.
Lee SM; Morcos Y; Jang H; Stuart JM; Levin MC
Curr Top Microbiol Immunol; 2005; 296():125-36. PubMed ID: 16323422
[TBL] [Abstract][Full Text] [Related]
4. Autoimmunity due to molecular mimicry as a cause of neurological disease.
Levin MC; Lee SM; Kalume F; Morcos Y; Dohan FC; Hasty KA; Callaway JC; Zunt J; Desiderio D; Stuart JM
Nat Med; 2002 May; 8(5):509-13. PubMed ID: 11984596
[TBL] [Abstract][Full Text] [Related]
5. IgG in brain correlates with clinicopathological damage in HTLV-1 associated neurologic disease.
Jernigan M; Morcos Y; Lee SM; Dohan FC; Raine C; Levin MC
Neurology; 2003 Apr; 60(8):1320-7. PubMed ID: 12707436
[TBL] [Abstract][Full Text] [Related]
6. Cross-reactivity between immunodominant human T lymphotropic virus type I tax and neurons: implications for molecular mimicry.
Levin MC; Lee SM; Morcos Y; Brady J; Stuart J
J Infect Dis; 2002 Nov; 186(10):1514-7. PubMed ID: 12404172
[TBL] [Abstract][Full Text] [Related]
7. Neuronal molecular mimicry in immune-mediated neurologic disease.
Levin MC; Krichavsky M; Berk J; Foley S; Rosenfeld M; Dalmau J; Chang G; Posner JB; Jacobson S
Ann Neurol; 1998 Jul; 44(1):87-98. PubMed ID: 9667596
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies to heterogeneous nuclear ribonuclear protein A1 (hnRNPA1) cause altered 'ribostasis' and neurodegeneration; the legacy of HAM/TSP as a model of progressive multiple sclerosis.
Levin MC; Lee S; Gardner LA; Shin Y; Douglas JN; Salapa H
J Neuroimmunol; 2017 Mar; 304():56-62. PubMed ID: 27449854
[TBL] [Abstract][Full Text] [Related]
9. Autoimmunity and molecular mimicry in tropical spastic paraparesis/human T-lymphotropic virus-associated myelopathy.
García-Vallejo F; Domínguez MC; Tamayo O
Braz J Med Biol Res; 2005 Feb; 38(2):241-50. PubMed ID: 15785836
[TBL] [Abstract][Full Text] [Related]
10. [Autoimmune syndrome in the tropical spastic paraparesis/myelopathy associated with human T-lymphotropic virus infections].
Domínguez MC; Torres M; Tamayo O; Criollo W; Quintana M; Sánchez A; García F
Biomedica; 2008 Dec; 28(4):510-22. PubMed ID: 19462556
[TBL] [Abstract][Full Text] [Related]
11. Pathological mechanisms of human T-cell lymphotropic virus type I-associated myelopathy (HAM/TSP).
Osame M
J Neurovirol; 2002 Oct; 8(5):359-64. PubMed ID: 12402162
[TBL] [Abstract][Full Text] [Related]
12. Post-translational glycosylation of target proteins implicate molecular mimicry in the pathogenesis of HTLV-1 associated neurological disease.
Lee S; Shin Y; Marler J; Levin MC
J Neuroimmunol; 2008 Nov; 204(1-2):140-8. PubMed ID: 18793806
[TBL] [Abstract][Full Text] [Related]
13. Virological aspects of tropical spastic paraparesis/HTLV-I associated myelopathy and HTLV-I infection.
Gessain A
J Neurovirol; 1996 Oct; 2(5):299-306. PubMed ID: 8912206
[TBL] [Abstract][Full Text] [Related]
14. Human T-lymphotropic virus type 1 (HTLV-1) and cellular immune response in HTLV-1-associated myelopathy/tropical spastic paraparesis.
Nozuma S; Kubota R; Jacobson S
J Neurovirol; 2020 Oct; 26(5):652-663. PubMed ID: 32705480
[TBL] [Abstract][Full Text] [Related]
15. Anti-Tax antibody levels in asymptomatic carriers, oligosymptomatic carriers, patients with rheumatologic disease or with HAM/TSP do not correlate with HTLV-1 proviral load.
de Souza JG; da Fonseca FG; Martins ML; Martins CP; de Carvalho LD; Coelho-dos-Reis JG; Carneiro-Proietti AB; Martins-Filho OA; Barbosa-Stancioli EF;
J Clin Virol; 2011 Jan; 50(1):13-8. PubMed ID: 20951636
[TBL] [Abstract][Full Text] [Related]
16. [Immunopathogenesis and treatment of the myelopathy associated to the HTLV-I virus].
Carod-Artal FJ
Rev Neurol; 2009 Feb 1-15; 48(3):147-55. PubMed ID: 19206063
[TBL] [Abstract][Full Text] [Related]
17. The IL-18, IL-12, and IFN-γ expression in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients, HTLV-1 carriers, and healthy subjects.
Bidkhori HR; Hedayati-Moghaddam MR; Mosavat A; Valizadeh N; Tadayon M; Ahmadi Ghezeldasht S; Rafatpanah H; Rezaee SA
J Neurovirol; 2020 Jun; 26(3):338-346. PubMed ID: 32270468
[TBL] [Abstract][Full Text] [Related]
18. Antibody transfection into neurons as a tool to study disease pathogenesis.
Douglas JN; Gardner LA; Lee S; Shin Y; Groover CJ; Levin MC
J Vis Exp; 2012 Sep; (67):. PubMed ID: 23051967
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneous nuclear ribonucleoprotein A1 in health and neurodegenerative disease: from structural insights to post-transcriptional regulatory roles.
Bekenstein U; Soreq H
Mol Cell Neurosci; 2013 Sep; 56():436-46. PubMed ID: 23247072
[TBL] [Abstract][Full Text] [Related]
20. HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP): the role of HTLV-I-infected Th1 cells in the pathogenesis, and therapeutic strategy.
Nakamura T
Folia Neuropathol; 2009; 47(2):182-94. PubMed ID: 19618340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
